5-Minute Pharma Daily

Niche News update on our upcoming relaunch with enhanced journalistic standards,  better source verification, and daily coverage across multiple topics.  We're returning soon with improved quality and uninterrupted service.

FDA approves ketamine for surgical pain management as PharmaTher achieves historic milestone. Tonix Pharmaceuticals approaches critical fibromyalgia drug approval deadline.

FDA grants accelerated approval for Jazz Pharmaceuticals' Modeyso, Biogen's Alzheimer's treatment awaits subcutaneous formulation decision, and RemeGen advances cancer therapy trials.

The FDA launches its PreCheck Program to speed up approvals, while the FTC moves to block Edwards Lifesciences' acquisition of JenaValve. Leadership changes at an FDA center may impact future timelines.